BRCA1 and ovarian cancer: In the OV_BRCA1 group, we observed overexpression of RCCD1, which was previously identified as a susceptibility locus for ovarian cancer [31], and of SUSD2, which promotes cancer metastasis and associates with cisplatin resistance [32].